Form 4: Masimo CEO Catherine Szyman Acquires 33,424 Restricted Stock Units
SEC Form 4 Filing
Catherine M. Szyman, CEO of Masimo Corp, reports the acquisition of 33,424 restricted stock units (RSUs) on February 12, 2025, vesting over three years.
Summary
- Catherine M. Szyman, CEO of Masimo Corporation, filed a Form 4 on February 14, 2025.
- The filing reports a transaction on February 12, 2025, where Szyman acquired 33,424 Restricted Stock Units (RSUs).
- Each RSU represents the right to receive one share of Masimo's common stock upon vesting.
- The RSUs will vest ratably over three years, with one-third vesting on each anniversary of the grant date (February 12, 2025).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of an RSU grant, which is neither overtly positive nor negative. The vesting schedule implies a commitment from the CEO.
Positives
- The acquisition of RSUs by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The vesting schedule of the RSUs suggests a commitment from the CEO for at least the next three years.
Industry Context
Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. RSU grants are a common form of executive compensation in the technology and medical device industries.
Comparison to Industry Standards
- RSU grants are a typical component of executive compensation packages in publicly traded companies, particularly in the tech and healthcare sectors.
- Vesting schedules of three years are also standard practice to incentivize long-term commitment.
- Comparing the size of this RSU grant to those of CEOs at similarly sized medical device companies (e.g., Medtronic, Stryker) would provide a benchmark for assessing its relative value.
Stakeholder Impact
- The RSU grant aligns the CEO's interests with those of the shareholders, as the value of the RSUs is tied to the company's stock performance.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Date of RSU transaction and grant. |
| 02/12/2026 | First vesting date for one-third of the RSUs. |
| 02/14/2025 | Date of Form 4 filing. |
| 02/12/2035 | Expiration date of the Restricted Stock Units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.